Want to join the conversation?
Medical device company $ZBH reported that its 3Q15 diluted EPS decreased 89.1% to $0.11, and adjusted diluted EPS increased 13.1% to $1.64. Net earnings were $22.2MM on a reported basis and $338.4MM on an adjusted basis, an increase of 35.5% adjusted over the prior year period.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.